RT Journal Article
SR Electronic
T1 Markovian Random Walk Modeling and Visualization of the Epidemic Spread of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.12.20062927
DO 10.1101/2020.04.12.20062927
A1 Akay, Haluk
A1 Barbastathis, George
YR 2020
UL http://medrxiv.org/content/early/2020/04/17/2020.04.12.20062927.abstract
AB The epidemic spread of CoVID-19 has resulted in confirmed cases of viral respiratory illness in more than 1.4 million people around the world as of April 7th, 2020 [1]. However, different regions have experienced the spread of this disease differently. Here, we develop a Markovian random-walk spatial extension of a quarantine-enhanced SIR model to measure, visualize and forecast the effect of susceptible population density, testing rate, and social distancing and quarantine policies on epidemic spreading. The model is used to simulate the spread of CoVID-19 in the regions of Hubei, China; South Korea; Iran; and Spain. The model allows for evaluating the results of different policies both quantitatively and visually as means of better understanding and controlling the spread of the disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was partially funded by the Intelligence Advanced Research Projects Activity (IARPA.)Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in manuscript is cited in reference section. The foremost dataset is included in the URL section following, as well as cited in the reference section. https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data/csse_covid_19_time_series